With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Translating BET Bromodomain Inhibitors for Acute Myeloid Leukemia Therapy||Dana-Farber Cancer Institute / Yana Pikman, MD||Young Investigator Grants||2014||Massachusetts|
|Ca2+ Release Activated Ca2+ (CRAC) Channels in Control of Leukemic Cell Metabolism and Leukemia Stem Cell Maintenance in T-ALL||New York University School of Medicine / Mate Maus, PhD||Young Investigator Grants||2014||New York|
|Development of Targeted DNA-damaging Therapy for ATRX-deficient Pediatric Glioblastoma||University of Michigan / Carl Koschmann, MD||Young Investigator Grants||2014||Michigan|
|Immunotherapy Of Neuroblastoma With Natural Killer T Cells Engineered To Target O-acetyl-GD2||Baylor College of Medicine / Andras Heczey, MD||Young Investigator Grants||2014||Texas|
|Targeting the Thymic Stromal Lymphopoeitin Receptor Signaling Axis to Reduce Relapse of High Risk Pediatric Acute Lymphoblastic Leukemia||National Cancer Institute / Christopher Chien, PhD||Young Investigator Grants||2014||Maryland|
|Targeting eEF2 Kinase in Neuroblastoma||University of California San Francisco / William Weiss, M.D., Ph.D.||Innovation Grants||2014||California|
|The Tumor Suppressive Role of LNK (SH2B3) in Acute Lymphoblastic Leukemia||Children's Hospital of Philadelphia / Wei Tong, PhD||Innovation Grants||2014||Pennsylvania|
|Trib2 in the Pathogenesis of T-ALL||University of Pennsylvania / Warren Pear, M.D., Ph.D.,||Innovation Grants||2014||Pennsylvania|
|Identifying Drug Resistant Mutations in Ph-like Acute Lymphoblastic Leukemia||University of California San Francisco / Mignon Loh, M.D.||Innovation Grants||2014||California|
|Developing Personalized (precision) Medicine Strategies to Optimize Pediatric Brain Tumor Management||Washington University / David Gutmann, M.D., Ph.D.||Innovation Grants||2014||Missouri|